
Astellas Pharma Inc
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
What If You Bought ALPMY Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Apr 2, 2014 | $11.69 | 5-for-4 | 1.25× | 5× |
| May 13, 2013 | $11.23 | 4-for-1 | 4× | 4× |
Astellas Pharma Inc Market Cap Timeline
Market capitalization from public listing to today. Split markers cover 2 current-security splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.